美股市场个股详情
ALZN Alzamend Neuro
- 0.7350
- +0.0170+2.37%
收盘价 05/02 16:00 (美东)
- 0.7451
- +0.0101+1.37%
盘后 17:59 (美东)
504.71万总市值-403市盈率TTM
0.7400最高价0.7000最低价2.56万股成交量0.7400今开0.7180昨收1.84万成交额0.53%换手率亏损市盈率(静)686.68万总股本11.910052周最高-1.18市净率355.15万流通值0.651652周最低--股息TTM483.20万流通股503.2500历史最高--股息率TTM5.57%振幅0.6516历史最低0.7160平均价1股每手
Alzamend Neuro股票讨论区
登录发表评论
Mental Health Biotech Catalyst Watchlist
$万达生物制药(VNDA.US$ PDUFA
$Intra-Cellular Therapies(ITCI.US$ Phase 3
$施贵宝(BMY.US$ PDUFA
$Alzamend Neuro(ALZN.US$ Phase 2
$Alzamend Neuro(ALZN.US$ Phase 2a
$Intra-Cellular Therapies(ITCI.US$ Phase 3
$施贵宝(BMY.US$ PDUFA
$Alzamend Neuro(ALZN.US$ Phase 2
$Alzamend Neuro(ALZN.US$ Phase 2a
4
2
$Alzamend Neuro(ALZN.US$ 缓慢上升趋势中📈
MILTON BOUGHT SOME SHARES! Hehehe
$Alzamend Neuro(ALZN.US$ 10% Shareholder AULT MILTON C III purchased 700 shares of Common Stocks on Dec 22, 26, 2023 at an average price of $0.9069 for a total value of $634.84.
2
News
$Alzamend Neuro(ALZN.US$ Alzamend Neuro Receives FDA "Study May Proceed" Notification for a Phase IIA Clinical Trial of AL001, a Next‑Generation Lithium Therapeutic Drug Candidate, in Post-Traumatic Stress Disorder Patients
1
End of the day move back up near previous close
$Alzamend Neuro(ALZN.US$ In at 1.19. Sell at 1.80. Thats 50% profit.
4
8
暂无评论
分析
目标价预测
暂无数据
热议
美股
综合热度
股票代码
最新价
涨跌幅
benji Cohan :
Srav Reddy : Much appreciate your help on these Biotech things. Appreciate if you can cover $XFOR too.